DekaBank Deutsche Girozentrale’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-85,642
| Closed | -$233K | – | 1172 |
|
|
2025
Q4 | $233K | Hold |
85,642
| – | – | ﹤0.01% | 1115 |
|
|
2025
Q3 | $456K | Hold |
85,642
| – | – | ﹤0.01% | 1004 |
|
|
2025
Q2 | $458K | Hold |
85,642
| – | – | ﹤0.01% | 997 |
|
|
2025
Q1 | $252K | Hold |
85,642
| – | – | ﹤0.01% | 1075 |
|
|
2024
Q4 | $263K | Hold |
85,642
| – | – | ﹤0.01% | 1105 |
|
|
2024
Q3 | $258K | Hold |
85,642
| – | – | ﹤0.01% | 1116 |
|
|
2024
Q2 | $290K | Hold |
85,642
| – | – | ﹤0.01% | 1093 |
|
|
2024
Q1 | $263K | Hold |
85,642
| – | – | ﹤0.01% | 1110 |
|
|
2023
Q4 | $363K | Sell |
85,642
-40,000
| -32% | -$217K | ﹤0.01% | 1103 |
|
|
2023
Q3 | $820K | Hold |
125,642
| – | – | ﹤0.01% | 915 |
|
|
2023
Q2 | $1.38M | Hold |
125,642
| – | – | ﹤0.01% | 828 |
|
|
2023
Q1 | $851K | Buy |
125,642
+120,000
| +2,127% | +$1.05M | ﹤0.01% | 904 |
|
|
2022
Q4 | $34K | Buy |
5,642
+3,701
| +191% | +$27.3K | ﹤0.01% | 1314 |
|
|
2022
Q3 | $15K | Hold |
1,941
| – | – | ﹤0.01% | 1361 |
|
|
2022
Q2 | $27K | Buy |
+1,941
| New | +$32.1K | ﹤0.01% | 1339 |
|
|
2021
Q2 | – | Sell |
-75,834
| Closed | -$6.93M | – | 1394 |
|
|
2021
Q1 | $6.93M | Buy |
75,834
+18,884
| +33% | +$1.83M | 0.02% | 412 |
|
|
2020
Q4 | $5.14M | Sell |
56,950
-378,550
| -87% | -$29M | 0.02% | 446 |
|
|
2020
Q3 | $21.7M | Buy |
+435,500
| New | +$24.3M | 0.1% | 191 |
|
DekaBank Deutsche Girozentrale's CVAC Position: Q1 2026 in Review
DekaBank Deutsche Girozentrale sold out of CureVac (CVAC) in Q1 2026, closing a stake of 85,642 shares — an estimated $233K sold.
DekaBank Deutsche Girozentrale first reported a position in CVAC in Q3 2020 and held it in 18 quarters. The position peaked at $21.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.
- DekaBank Deutsche Girozentrale reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
- DekaBank Deutsche Girozentrale sold 85,642 CureVac shares in Q1 2026, an estimated $233K.
- DekaBank Deutsche Girozentrale first reported a position in CureVac in Q3 2020 and held it in 18 quarters.
- DekaBank Deutsche Girozentrale's CureVac position peaked at $21.7M in Q3 2020.
- 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.